Advanced Ultrasound in Pleural Infection
AUDIO
1 other identifier
interventional
20
1 country
2
Brief Summary
Pleural infection is a potentially serious infection of the fluid normally found around the lung and current evidence suggests its incidence is increasing in both adult and paediatric populations. Identification of bacterial pathogens causing pleural infection is of paramount importance in the clinical care of patients are currently, only 40% of patients have a laboratory confirmed microbiological diagnosis for their pleural infection. An unclear diagnosis can be due to various reasons such as a small sample volume therefore the aim of the AUDIO study is to ascertain the capacity of pleural biopsies in improving the microbiological yield of pleural infection. Currently, there are no well validated methods for identifying patients presenting with pleural infection on the basis of initial ultrasound imaging. The AUDIO study will define the role of baseline thoracic ultrasound in predicting the radiographic, clinical and surgical outcomes of patients with pleural infection. The AUDIO study aims to recruit 50 patients from 2 centres with specific pleural expertise and these patients will be followed up over a 12 month period. Investigators hope that through the information gathered from ultrasound imaging and pleural biopsies, it will aid physicians' clinical and therapeutic decision making when treating patients with pleural infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2015
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 21, 2015
CompletedFirst Posted
Study publicly available on registry
November 20, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2017
CompletedMay 16, 2017
May 1, 2017
1.9 years
October 21, 2015
May 15, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
To increase microbiological yield.
Positive microbiological results on pleural biopsy at baseline compared with positive microbiological results on pleural fluid.
Secondary Outcomes (5)
Radiographic improvement in area of pleural collection measured by the percentage of the ipsilateral hemithorax occupied by effusion on chest radiography.
Day 1 and Day 7
Mortality from pleural infection
3 and 12 months
Duration of hospital (in patient) stay
From the date of initial hospital admission to the date of discharge assessed up to 2 weeks.
Necessity for surgical fluid drainage documented in case report forms over study completion
3 and 12 months
Pleural fluid drainage over 7 days
First 7 days of trial involvement
Interventions
6 - 8 pleural biopsy samples will be taken before the insertion of the chest drain. These samples will be sent to microbiology for examination.
Eligibility Criteria
You may qualify if:
- A clinical presentation compatible with pleural infection
- A pleural fluid collection that may or (rarely according to clinical judgement) may not require drainage that meets at least one or more of the following criteria:
- Purulent
- Gram stain positive for bacteria
- Bacterial culture positive
- Acidic with a pH \<7.2
- Low pleural fluid glucose \<3mmol/L (\<55mg/dL)
- CT evidence of pleural infection (consolidation of underlying lung with enhancing pleural collection on contrast-enhanced CT)
You may not qualify if:
- Age \<18 years
- No pleural fluid available for analysis
- Previous pneumonectomy on the side of pleural infection
- Expected survival \<3 months due to co-morbid disease
- Inability to give informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
North Bristol NHS Trust, Southmead Hospital
Bristol, BS10 5NB, United Kingdom
Oxford Respiratory Trials Unit, Churchill Hospital
Oxford, OX3 7LE, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 21, 2015
First Posted
November 20, 2015
Study Start
May 1, 2015
Primary Completion
March 14, 2017
Study Completion
March 14, 2017
Last Updated
May 16, 2017
Record last verified: 2017-05